List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 17 studies with search of: "Angiomatosis"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Registry for Vascular Anomalies Associated With Coagulopathy
Conditions: Multifocal Lymphangioendotheliomatosis With Thrombocytopenia;   Cutaneovisceral Angiomatosis With Thrombocytopenia;   Vascular Anomaly With Thrombocytopenia;   Hemangiomas
Intervention: Other: no intervention
2 Active, not recruiting Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease
Conditions: Hemangioblastoma;   Hippel Lindau Disease
Intervention:
3 Completed Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)
Condition: Sturge - Weber Syndrome (SWS)
Intervention:
4 Completed Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584
Conditions: Von Hippel-Lindau Disease;   CNS Hemangioblastoma;   Retinal Hemangioblastoma
Intervention: Drug: PTK787/ZK 222584
5 Recruiting Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Sunitinib Malate
6 Recruiting Genetic Study of Patients With Inherited Urologic Malignancies
Conditions: Birt Hogg Dube Syndrome;   Kidney Cancer;   Multiple Endocrine Neoplasia 1 and 2 (men1, men2);   Von Hippel-Lindau Syndrome
Interventions: Genetic: DNA ploidy analysis;   Genetic: genetic linkage analysis;   Genetic: mutation analysis;   Genetic: polymorphic microsatellite marker analysis;   Other: medical chart review
7 Recruiting Melphalan and Mannitol in Treating Patients With Central Nervous System Cancer
Conditions: Brain and Central Nervous System Tumors;   Chordoma;   Lymphoma;   Von Hippel-Lindau Syndrome
Interventions: Drug: mannitol;   Drug: melphalan
8 Recruiting Use of the Atkins Diet for Children With Sturge Weber Syndrome
Conditions: Epilepsy;   Sturge Weber Syndrome
Intervention: Dietary Supplement: modified Atkins diet
9 Completed Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome
Conditions: Kidney Cancer;   Von Hippel-Lindau Syndrome
Intervention: Genetic: mutation analysis
10 Recruiting Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: SU011248
11 Completed Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Ranibizumab
12 Active, not recruiting Genetic Study of Patients With Von Hippel-Lindau Syndrome
Condition: Kidney Cancer
Intervention: Genetic: polymorphic microsatellite marker analysis
13 Active, not recruiting Diagnostic and Genetic Study to Identify Pancreatic Lesions in Patients With Von Hippel-Lindau Syndrome
Conditions: Neuroendocrine Carcinoma;   Pancreatic Cancer;   Von Hippel-Lindau Syndrome
Interventions: Genetic: comparative genomic hybridization;   Genetic: mutation analysis;   Genetic: proteomic profiling;   Procedure: computed tomography;   Procedure: magnetic resonance imaging;   Procedure: ultrasound imaging
14 Completed Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors
Conditions: Deafness;   Kidney Diseases;   Kidney Neoplasms;   Neoplasms;   Retinal Diseases
Intervention:
15 Completed 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Von Hippel-Lindau Disease and Kidney Cancer
Conditions: Kidney Cancer;   Von Hippel-Lindau Syndrome
Intervention: Drug: tanespimycin
16 Recruiting Vandetanib in Treating Patients With Von Hippel-Lindau Syndrome and Kidney Tumors
Conditions: Kidney Cancer;   Von Hippel-Lindau Syndrome
Interventions: Drug: vandetanib;   Genetic: gene expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: flow cytometry;   Other: laboratory biomarker analysis
17 Completed EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
Condition: Hippel-Lindau Disease
Intervention: Drug: EYE001

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services